TuHURA Biosciences (HURA) Cash from Financing Activities (2012 - 2026)
TuHURA Biosciences' Cash from Financing Activities came in at $3.47 million for Q2 2026, down 60.1% from $8.7 million a year earlier and down 51.4% from the prior quarter.
Powered by 
Analysis
TuHURA Biosciences (HURA) Cash from Financing Activities (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, TuHURA Biosciences reported Cash from Financing Activities of $22.39 million, down 57.0% year-over-year; for FY2025, it came in at $19.93 million, down 33.1% from FY2024.
- Cash from Financing Activities carries a five-year compound annual growth rate of 24.7% (FY2020 to FY2025).
- Going back by year, Cash from Financing Activities was $29.77 million in FY2024, $2.66 million in FY2023, $21.64 million in FY2022 (-16.9%) and $26.04 million in FY2021 (+294.5%).
- The Q2 2026 figure represents the lowest quarterly Cash from Financing Activities since Q1 2025.
- Business Quant data shows HURA's Cash from Financing Activities at $7.14 million (Q1 2026), $6.51 million (Q4 2025) and $5.27 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -47.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -3.66 Bn |
| 10 | TuHURA Biosciences | 35.65 Mn | 35.65 Mn | - | 3.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.47 Mn |
| Mar 31, 2026 | 7.14 Mn |
| Dec 31, 2025 | 6.51 Mn |
| Sep 30, 2025 | 5.27 Mn |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | -547,878.00 |
| Mar 31, 2024 | 4.63 Mn |
| Dec 31, 2023 | 806,249.00 |
| Sep 30, 2023 | -2,000.00 |
| Mar 31, 2023 | -2,000.00 |
| Dec 31, 2022 | 1.86 Mn |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 7.93 Mn |
| Mar 31, 2022 | -2,000.00 |
| Dec 31, 2021 | -171,000.00 |
| Sep 30, 2021 | 13.88 Mn |
| Jun 30, 2021 | -492,000.00 |
| Mar 31, 2021 | 3.20 Mn |
| Dec 31, 2020 | -16,000.00 |
| Sep 30, 2020 | 23.35 Mn |
API Access
TuHURA Biosciences Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=HURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "HURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=HURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();